Medicollect gets new CEO

Medicollect was founded in 2012 by Henrik Vincentz and Torben Lind. Since then the company has grown its client base substantially, and the business has proved its sustainability.

In order to strengthen its international profile, the founders have decided to invite a new partner and CEO into the company, and the choice has fallen on Rene Vind Ludwigs, who with his experience in pharma and medical device industry brings strong skills and a comprehensive knowledge of customers’ business processes .

“We are absolutely convinced that we have made the right choice by inviting Rene Ludwig in as a partner”, says the founder, Henrik Vincentz.

Rene Ludwig comes from a position as CSO at Mission Pharma and before that he worked several years as General Manager at GN Resound and at Ambu.

Medicollect’s management now consists of CEO Rene Ludwig, COO Torben Lind and CCO Henrik Vincentz.

blog-example

Patient recruitment company, Medicollect, in close cooperation with Danish Diabetes Association

Medicollect has taken the initiative to establish the Danish group for diabetics who want to participate in clinical research, The Diabetics Panel.

Danish Diabetes Association will invite their members to sign up for the free membership of The Diabetics Panel, and by doing so, they acknowledges their members’ wish to know about the current diabetes research.

Medicollect also acknowledge the importance of the work done by Danish Diabetes Association, and will therefore send out information to all panel members about Danish Diabetes Association.

Medicollect is proud of this cooperation, and Torben Lind, COO, states: “Cooperation at such strategic level is a testimony to the seriousness, and professionalism with which we work, and we are proud to be acknowledged by a institution as fundamental for Danish diabetics as Danish Diabetics Association”.

So far, the cooperation spans until summer 2015, with the possibility of being prolonged into a more ongoing framework.

Want to know more?
Contact Torben Lind

blog-msd

Patient recruitment company, Medicollect, continues final vendor qualification streak with MSD

Earlier this year, Medicollect achieved its first vendor milestone, when worlds second largest pharmaceutical company, Novartis, finalized the detailed vendor qualification process.

Now, MSD has also approved all SOP’s submitted by Medicollect for vendor qualification, making it the second finalized procedure from a global pharmaceutical company in mere months.

Pharmaceutical companies and CROs have shown huge interest in Medicollect’s services. It is a clear testimony to Medicollect’s innovative aspects and professionalism that global pharmaceutical companies are eager to enter into vendor partnerships with Medicollect.

As Torben Lind, COO in Medicollect, phrases it: “Medicollect focuses exclusively on solving the recruitment challenge faced by companies involved with clinical trial, and our services come across as the best solution the market has to offer right now”.

Want to know more?
Contact Torben Lind